Advocacy intelligence hub — real-time data for patient organizations
West Virginia University
nChroma Bio — PHASE1, PHASE2
Tune Therapeutics, Inc. — PHASE1
Nanfang Hospital, Southern Medical University
M.D. Anderson Cancer Center — NA
Virion Therapeutics — PHASE1
Inmunotek S.L. — NA
Barinthus Biotherapeutics — PHASE2
SCENESSE®: FDA approved
SCENESSE® is indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP)
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs